|
|
Julia Menke, Yasunori Iwata, Whitney A. Rabacal, Ranu Basu, Yee G. Yeung, Benjamin D. Humphreys, Takashi Wada, Andreas Schwarting, E. Richard Stanley, Vicki R. Kelley
J Clin Invest. 2009;
119(8):2330
doi:10.1172/JCI39087
Abstract |
Full text
| PDF
| Supplemental material

T
ubular damage following ischemic renal injury is often reversible, and tubular epithelial cell (TEC) proliferation is a hallmark of tubular repair. Macrophages have been implicated in tissue repair, and CSF-1, the principal macrophage growth factor, is expressed by TECs. We therefore tested the hypothesis that CSF-1 is central to tubular repair using an acute renal injury and repair model, ischemia/reperfusion (I/R). Mice injected with CSF-1 following I/R exhibited hastened healing, as evidenced by decreased tubular pathology, reduced fibrosis, and improved renal function. Notably, CSF-1 treatment increased TEC proliferation and reduced TEC apoptosis. Moreover, administration of a CSF-1 receptor–specific (CSF-1R–specific) antibody after I/R increased tubular pathology and fibrosis, suppressed TEC proliferation, and heightened TEC apoptosis. To determine the contribution of macrophages to CSF-1–dependent renal repair, we assessed the effect of CSF-1 on I/R in mice in which CD11b+ cells were genetically ablated and determined that macrophages only partially accounted for CSF-1–dependent tubular repair. We found that TECs expressed the CSF-1R and that this receptor was upregulated and coexpressed with CSF-1 in TECs following renal injury in mice and humans. Furthermore, signaling via the CSF-1R stimulated proliferation and reduced apoptosis in human and mouse TECs. Taken together, these data suggest that CSF-1 mediates renal repair by both a macrophage-dependent mechanism and direct autocrine/paracrine action on TECs.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(17)
| Title and authors |
Publication |
Year |
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
D. A. Hume, K. P. A. MacDonald
|
Blood
|
2012 |
Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction
Naïke Bige, Nasim Shweke, Safa Benhassine, Chantal Jouanneau, Sophie Vandermeersch, Jean-Claude Dussaule, Christos Chatziantoniou, Pierre Ronco, Jean-Jacques Boffa
|
Kidney Int
|
2012 |
Augmenter of Liver Regeneration Attenuates Tubular Cell Apoptosis in Acute Kidney Injury in Rats: The Possible Mechanisms
Xiao-hui Liao, Guo-tao Chen, Ying Li, Ling Zhang, Qi Liu, Hang Sun, Hui Guo
|
Ren Fail
|
2012 |
Colony-Stimulating Factor-1 Promotes Kidney Growth and Repair via Alteration of Macrophage Responses
Maliha A. Alikhan, Christina V. Jones, Timothy M. Williams, Anthony G. Beckhouse, Anne L. Fletcher, Michelle M. Kett, Samy Sakkal, Chrishan S. Samuel, Robert G. Ramsay, James A. Deane, Christine A. Wells, Melissa H. Little, David A. Hume, Sharon D. Ricardo
|
The American Journal of Pathology
|
2011 |
Ischemic kidney injury and mechanisms of tissue repair
Marwa El Sabbahy, Vishal S. Vaidya
|
WIREs Syst Biol Med
|
2011 |
Current Protocols in Immunology
Violeta Chitu, Yee-Guide Yeung, Wenfeng Yu, Sayan Nandi, E. Richard Stanley
|
Current Protocols in Immunology
|
2011 |
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation
D. Hashimoto, A. Chow, M. Greter, Y. Saenger, W.-H. Kwan, M. Leboeuf, F. Ginhoux, J. C. Ochando, Y. Kunisaki, N. van Rooijen, C. Liu, T. Teshima, P. S. Heeger, E. R. Stanley, P. S. Frenette, M. Merad
|
Journal of Experimental Medicine
|
2011 |
Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function
James A. Thomas, Caroline Pope, Davina Wojtacha, Andrew J. Robson, Timothy T. Gordon-Walker, Stephen Hartland, Prakash Ramachandran, Marielle Van Deemter, David A. Hume, John P. Iredale, Stuart J. Forbes
|
Hepatology
|
2011 |
Nierenbeteiligung beim systemischen Lupus erythematodes
A. Schwarting
|
Nephrologe
|
2011 |
Potential of the Side Population in Regenerative Nephrology
M.H. Little, G.A. Challen
|
Regenerative Nephrology
|
2011 |
|